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In a challenging case of carotid occlusion with slowly evolving stroke, we used brain imaging to facilitate endovascular
revascularization resulting in the relief of the patient’s symptoms. Patients with carotid occlusion and continued neurological
worsening or ﬂuctuations present enormous treatment challenges. These patients may present “slow” strokes with subacute
infarcts that present signiﬁcant challenges and risks during attempts at revascularization of the occluded artery. We present such a
case in which we used multimodal imaging techniques, including MR-perfusion, to facilitate endovascular revascularization. Our
approach of delayed but cautious intra-arterial thrombolytic therapy, guided by brain imaging, and followed by stent placement
across the residual stenosis, enabled revascularization of the occluded artery without overt in-hospital complications.
1.Introduction
The management of ischemic stroke patients with acute
carotid artery occlusion who experience neurological wors-
ening is challenging and may require innovative approaches.
The coexistence of carotid artery occlusion and evolving
stroke symptoms poses major treatment challenges because
of the presence of recent brain infarcts. Aggressive interven-
tions with an aim of revascularization of the carotid artery
are put on hold to avoid complications of reperfusion injury
at the infarct sites. One such intervention, intra-arterial
thrombolysis, is oﬀered within six hours of onset in anterior
circulation ischemic stroke [1]. Treatment beyond the 6-
hour window is associated with high risks of complications
with limited chances of neurological improvement. In this
report, we present an unusual case of a patient with acute
carotidocclusionwhodevelopedneurologicalworseningand
ﬂuctuations (“slow” stroke) that required complex man-
agement decisions. Our approach was to perform delayed,
but closely monitored, intra-arterial thrombolysis four days
from initial stroke presentation. Our goal in presenting
this case is to raise awareness of management challenges
in the subacute phase of an ischemic stroke and highlight
an interventional approach that may improve the patient’s
outcome. We show thatdelayed intra-arterial thrombolysis is
achievable with improvement in the patient’s condition and
without untoward consequences.
2.ClinicalSummary
The patient is a 66-year-old African American female who
presented with repeated clinical events of brain ischemia and
imaging conﬁrmation of an infarct. She had a history of
hypertension, type 2 diabetes mellitus, and hyperlipidemia.
Initially, she presented to an outside hospital with a sudden-
onsetofslurredspeechthatlasted2hours.Shewasdiagnosed
with transient ischemic attack (TIA) before discharge home
onoralantiplatelettherapy.Thefollowingday,shedeveloped
another episode of slurred speech associated with left-sided
weakness involving the face, arm, and leg. On presentation
to the same outside facility, brain imaging revealed a right
basal ganglia infarct with distal right internal carotid artery2 Stroke Research and Treatment
(ICA) stenosis. She was started on heparin infusion for
possible dissection of the distal right ICA and transferred
to our facility for a higher level of care. Her home medi-
cations included lisinopril, atorvastatin, long-acting insulin,
rosiglitazone, and glyburide. Family history indicated her
grandmother had a stroke of unclear cause. She did not
smoke,drinkalcohol,oruseillicitdrugs.Clearly,herhospital
transfer indicated a deteriorating ischemic process of the
brain that was referable to carotid artery pathology.
The patient’s subsequent hospitalization was marked
by episodes of neurological worsening. On transfer to our
facility three days from her initial TIA symptoms, her blood
pressure was 155/81mmHg and heart rate was105 beats per
minute(bpm).Neurologicalexaminationrevealedamildleft
facial droop with an NIH stroke scale (NIHSS) score of 1;
other aspects of neurological and systemic examination were
unremarkable.AheadCTscanshowedtherightbasalganglia
infarct, and CT angiography conﬁrmed the ICA stenosis.
She was started on antiplatelet therapy (clopidogrel) and
discontinued heparin treatment. Within 10 hours of transfer,
she developed the ﬁrst neurological worsening in our facility.
She had a partial right gaze preference, partial left visual
ﬁeld cut, more prominent left facial droop, and left arm
drift (NIHSS 4). Her vital signs at this time indicated a
drop in blood pressure to 115/55mmHg, with a pulse rate
of 79bpm. She received additional normal saline infusion
and was started on eptiﬁbatide infusion. Seven hours from
onset of worsening, she improved to the point of having no
neurological deﬁcits (NIHSS 0). Her blood pressure at that
time was 145/75mmHg with pulse rate of 77bpm. The next
day (four days from initial TIA symptoms), we performed
a cerebral angiogram to better deﬁne her vasculature and
identiﬁed a right carotid terminus (carotid T) occlusion.
The right anterior cerebral artery (ACA) was perfused from
the anterior communicating (A-Comm) artery while the
right middle cerebral artery (MCA) territory was perfused
by leptomeningeal collaterals and right posterior cerebral
artery (PCA). No evidence of carotid artery dissection was
found. No interventional revascularization procedure was
attempted at this point given recent infarct and potential
risks of reperfusion injury. Following the arteriography, she
continued to have neurological ﬂuctuations despite attempts
to keep her blood pressure elevated. Each time she sat up for
upto15minutes,shedevelopedaleft-faceandarmweakness
typically with a drop in systolic blood pressure to below
114mmHg. Notably, she was remarkably frustrated (she felt
miserable, saying she would rather die than continue to have
these episodes) though her NIHSS score only worsened to a
score of 4. For this patient, her level of psychological distress
especially with inability to sit up was a major disability, a
feature not captured by the severity scale of NIHSS.
An MRI showed extensive perfusion defects suggest-
ing considerable risk of imminent brain damage, which
prompted our subsequent endovascular intervention. We
obtainedadditionalinvestigativestudiesincludingelectroen-
cephalogram (EEG) and echocardiography (both transtho-
racic and transesophageal); the results of these were unre-
markable. However, an MRI of the brain showed the
right basal ganglia infarct with extensive perfusion defect
in the right MCA territory (Figure 1) and no evidence
of hemorrhagic transformation of infarct. These ﬁndings,
in addition to the patient’s clinical condition, prompted
our endovascular intervention ﬁve days from her initial
TIA event. With the patient under conscious sedation and
being monitored for neurological status, we slowly infused
urokinase through a microcatheter at site of occlusion
(Figure 2(a)). After the intra-arterial infusion of 107,000
units of urokinase, the patency of the right ICA and
MCA were reestablished; perfusion of the lateral lenticu-
lostriate arteries became evident. However, an underlying
severe stenosis remained at the distal right ICA bifurcation
(Figure 2(b)). Again, due to concerns of reperfusion injury,
it was elected to proceed with treatment of the residual
stenosis at a later date. She remained free of neurological
ﬂuctuations following the procedure. Twelve days from her
initial symptoms, a balloon-mounted, drug-eluting 2.5 ×
8mm Cypher Stent (Cordis, Miami Lakes, Florida) was
successfully deployed at the stenotic segment of the right
supraclinoid ICA bifurcation. Complete recanalization was
achieved with the procedure, enabling an improvement in
ICA luminal diameter from 1mm to 2.5mm as shown in
Figure 3. Following the procedure, she was maintained on an
antiplatelet regimen of clopidogrel and aspirin to maintain
stent patency and measures to keep her systolic blood
pressure below 140mmHg to prevent hyperperfusion injury.
The patient was discharged home the following day without
neurological deﬁcits or further episodes of worsening.
3. Discussion
This case is striking because it highlights the use of slowly
delivered intra-arterial thrombolysis to revascularize an
occluded carotid artery terminus in the subacute ischemic
stroke period, followed by stenting of the residual stenosis.
This management approach was necessitated by the contin-
ued neurological ﬂuctuations despite conservative medical
measures. Also, there was imaging suggestive of additional
brain tissue at risk of further damage. This imaging infor-
mation provided the basis for our interventional approach.
The clinical presentation of our patient is unusual in that
she had an acute large vessel occlusion at the carotid T
and slowly developed very minimal neurological deﬁcits
accentuated with intermittent ﬂuctuations. Acute carotid
T occlusions are typically devastating with poor clinical
outcomes. The manner of our patient’s presentation, termed
“slow”stroke,isinvariablydiﬃculttotreatbecauseoftherisk
of reperfusion injury. Therefore, our therapeutic approach
was facilitated largely by serial brain imaging besides the
clinical ﬂuctuations exhibited by the patient. We used MR
imaging to delineate the infarct and brain tissue at risk
of dying (penumbra). The penumbra that persisted many
days from onset of initial insult presented a window of
opportunity for intervention. The presence of perfusion
defect or penumbra as estimated on MRI appears to be a
useful marker in identifying patients that could be treated
beyond the hyperacute period [2–5]. However, these studies
evaluated imaging markers of penumbra in patients withinStroke Research and Treatment 3
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Figure 1: Magnetic resonance imaging of the brain, (a) prethrombolysis diﬀusion-weighted image (DWI) shows brain infarct in the
right MCA territory, (b) prethrombolysis Perfusion-weighted image (PWI) shows right brain hemisphere with perfusion defect, (c)
prethrombolysis Magnetic resonance Angiography (MRA) shows absence of blood ﬂow in the right MCA, (d) postthrombolysis DWI shows
no signiﬁcant interval changes in brain parenchyma, and (e) postthrombolysis MRA with patent right MCA.
(a) (b)
Figure 2: (a) Slow injection of dilute urokinase with microcatheter at site of occlusion; (b) recanalization of the right MCA with residual
carotid stenosis.4 Stroke Research and Treatment
(a) (b)
Figure 3: (a) Prestenting cerebral arteriography shows occluded terminal carotid artery; (b) Poststenting arteriography shows complete
carotid recanalization.
6 hours of stroke onset and not days after as in our patient’s
case.
Our approach diﬀers from those of others who have
employed various means such as induction of hypertension.
Medically induced hypertension improves brain perfusion
and has been shown to ameliorate stroke symptoms beyond
the thrombolysis window [6, 7]. We were unable to stabilize
our patient’s condition with such conservative measures.
Also, it is possible that medically induced hypertension
using vasopressors on the long term could pose a risk of
damage in other vascular beds given a patient’s vascular risk
factors [1]. Even so, keeping her hypertensive in hospital was
diﬃcult suggesting that continuation of such therapy as an
outpatient would be impracticable. Had carotid dissection
been conﬁrmed on initial angiography, anticoagulation
could have been an option of medical therapy. Nonetheless,
we wereunable to achieve neurological stability with medical
therapy that consisted of antiplatelet therapy and attempts at
keeping the patient hypertensive. Revascularization of acute
carotid occlusion with thrombolysis and device-assisted
approaches is promising in the acute stroke setting [8].
Complications of such revascularization (procedures and
thrombolysis) and lack of palpable beneﬁt limit the use of
this therapeutic approach beyond the acute stroke period.
Typically, it is unlikely that our patient would be a candidate
for aggressive interventions to reopen the occluded carotid
artery given her presentation with initial negligible deﬁcits.
No doubt, her development of neurological worsening
despite conservative measures helped direct our therapeutic
approach. With the risk of hemorrhage from thrombolysis,
we considered mechanical thrombectomy as an alternative
methodofintervention.However,wewantedtoavoidabrupt
recanalization of the occluded artery that could precipitate
reperfusion injury especially in the setting of a subacute
infarct.Therefore,wedecidedonurokinaseinfusionwiththe
goal of slow carotid recanalization. Although recent reports
highlight the feasibility of delayed reperfusion modalities [9,
10], it remains to be determined whether our approach was
the optimum in the clinical setting. A systematic evaluation
of the approach, including long-term clinical outcomes, is
needed before it can be recommended.
Other treatment options appeared to be of limited
value in addressing the patient’s misery from neurological
ﬂuctuations. Arterial bypass surgery would be unlikely
to ameliorate the symptoms that early after the stroke.
Moreover, its beneﬁts in stroke patients remain unclear.
Though not common, carotid endarterectomy (CEA) has
been reportedly successful in some patients with acutely
occluded ICA [11]. In our patient, the location of the carotid
occlusion made such surgical revascularization untenable.
In such tenuous vascular locations, revascularization using
stent placement can be successfully achieved in patients
with acute carotid occlusion and subacute infarcts [12].
In conclusion, we demonstrate that delayed and closely
monitored intra-arterial therapy followed by stenting of
residual atherosclerotic stenosis is achievable in a patient
presenting with a subacute ischemic stroke and neurological
ﬂuctuations. In such a case, brain imaging showing evidence
of substantial brain tissue at risk with absence of hemor-
rhagic transformation is useful in facilitating management
decisions.
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